Tumor targeting nanoparticle E7_49-57-HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model

References

• Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–99. doi:10.1016/S0140-6736(13)60022-7.
   PubMed Web of Science ®Google Scholar
• Luria L, Cardoza-Favarato G. Human papillomavirus. In: StatPearls. Treasure Island (FL); 2020. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK448132/#article-23034.s2
   Google Scholar
• Iljazovic E, Mena M, Tous S, Alemany L, Omeragić F, Sadiković A, Clavero O, Vergara M, Bosch FX, De Sanjosé S, et al. Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina. Cancer Epidemiol. 2014;38(5):504–10. doi:10.1016/j.canep.2014.06.004.
   PubMed Web of Science ®Google Scholar
• Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359(9312):1093–101. doi:10.1016/S0140-6736(02)08151-5.
   PubMed Web of Science ®Google Scholar
• Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C. Therapeutic vaccines for HPV-associated malignancies. Immunotargets Ther. 2020;9:167–200. doi:10.2147/ITT.S273327.
   PubMed Web of Science ®Google Scholar
• Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, De Jongh BM, Drijfhout JW, Schegget JT, Melief CJM, Kast WM. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol. 1993;23(9):2242–49. doi:10.1002/eji.1830230929.
   PubMed Web of Science ®Google Scholar
• Khammanivong V, Liu XS, Liu WJ, Rodda SJ, Leggatt GR, Tindle RW, Frazer IH, Fernando GJP. Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16. Immunol Cell Biol. 2003;81(1):1–7. doi:10.1046/j.1440-1711.2003.01130.x.
   PubMed Web of Science ®Google Scholar
• Ren F, Xu Y, Mao L, Ou R, Ding Z, Zhang X, Tang J, Li B, Jia Z, Tian Z, et al. Heat shock protein 110 improves the antitumor effects of the cytotoxic T lymphocyte epitope E7(49-57) in mice. Cancer Biol Ther. 2010;9(2):134–41. doi:10.4161/cbt.9.2.10391.
   PubMed Web of Science ®Google Scholar
• Chen S, Ou R, Tang J, Deng X, Wu Y, Van Velkinburgh JC, Ni B, Xu Y. Enhanced anti-tumor effects of HPV16E7(49-57)-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150. Cancer Epidemiol. 2013;37(2):172–78. doi:10.1016/j.canep.2012.10.005.
   PubMed Web of Science ®Google Scholar
• Barrios K, Celis E. TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers. Cancer Immunol Immunother. 2012;61(8):1307–17. doi:10.1007/s00262-012-1259-8.
   PubMed Web of Science ®Google Scholar
• Goeckeler JL, Petruso AP, Aguirre J, Clement CC, Chiosis G, Brodsky JL. The yeast Hsp110, Sse1p, exhibits high-affinity peptide binding. FEBS Lett. 2008;582(16):2393–96. doi:10.1016/j.febslet.2008.05.047.
   PubMed Web of Science ®Google Scholar
• Murshid A, Gong J, Calderwood SK. The role of heat shock proteins in antigen cross presentation. Front Immunol. 2012;3:63. doi:10.3389/fimmu.2012.00063.
   PubMed Web of Science ®Google Scholar
• Segal BH, Wang XY, Dennis CG, Youn R, Repasky EA, Manjili MH, Subjeck JR. Heat shock proteins as vaccine adjuvants in infections and cancer. Drug Discov Today. 2006;11(11–12):534–40. doi:10.1016/j.drudis.2006.04.016.
   PubMed Web of Science ®Google Scholar
• Guo QY, Yuan M, Peng J, Cui X-M, Song G, Sui X, Lu S-B. Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma. J Exp Clin Cancer Res. 2011;30:24. doi:10.1186/1756-9966-30-24.
   PubMed Web of Science ®Google Scholar
• Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol. 2001;166(1):490–97. doi:10.4049/jimmunol.166.1.490.
   PubMed Web of Science ®Google Scholar
• Wang XY, Chen X, Manjili MH, Repasky E, Henderson R, Subjeck JR. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res. 2003;63:2553–60.
   PubMed Web of Science ®Google Scholar
• Kim HL, Sun X, Subjeck JR, Wang XY. Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110. Cancer Immunol Immunother. 2007;56(7):1097–105. doi:10.1007/s00262-006-0258-z.
   PubMed Web of Science ®Google Scholar
• Ding Z, Ou R, Ni B, Tang J, Xu Y. Cytolytic activity of the human papillomavirus type 16 E711-20 epitope-specific cytotoxic T lymphocyte is enhanced by heat shock protein 110 in HLA-A*0201 transgenic mice. Clin Vaccine Immunol. 2013;20(7):1027–33. doi:10.1128/CVI.00721-12.
   PubMedGoogle Scholar
• Danhier F, Le Breton A, Preat V. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm. 2012;9(11):2961–73. doi:10.1021/mp3002733.
   PubMed Web of Science ®Google Scholar
• Sun Y, Kang C, Liu F, Zhou Y, Luo L, Qiao H. RGD peptide-based target drug delivery of doxorubicin nanomedicine. Drug Dev Res. 2017;78(6):283–91. doi:10.1002/ddr.21399.
   PubMed Web of Science ®Google Scholar
• Katsamakas S, Chatzisideri T, Thysiadis S, Sarli V. RGD-mediated delivery of small-molecule drugs. Future Med Chem. 2017;9(6):579–604. doi:10.4155/fmc-2017-0008.
   PubMed Web of Science ®Google Scholar
• Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem. 2005;13(17):5043–54. doi:10.1016/j.bmc.2005.04.084.
   PubMed Web of Science ®Google Scholar
• Long Q, Zhu W, Guo L, Pu L. RGD-conjugated resveratrol HSA nanoparticles as a novel delivery system in ovarian cancer therapy. Drug Des Devel Ther. 2020;14:5747–56. doi:10.2147/DDDT.S248950.
   PubMed Web of Science ®Google Scholar
• Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol. 2000;18(1):33–37. doi:10.1038/71889.
   PubMed Web of Science ®Google Scholar
• Wu YZ, Zhao JP, Wan Y, Jia Z-C, Zhou W, Bian J, Ni B, Zou L-Y, Tang Y. Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo. J Virol. 2002;76(20):10264–69. doi:10.1128/JVI.76.20.10264-10269.2002.
   PubMed Web of Science ®Google Scholar
• Awasthi S, Cox RA. Transfection of murine dendritic cell line (JAWS II) by a nonviral transfection reagent. Biotechniques. 2003;35(3):600–602, 604. doi:10.2144/03353dd03.
   PubMed Web of Science ®Google Scholar
• Tian Z, Wang H, Jia Z, Shi J, Tang J, Mao L, Liu H, Deng Y, He Y, Ruan Z, et al. Tumor-targeted inhibition by a novel strategy - mimoretrovirus expressing siRNA targeting the Pokemon gene. Curr Cancer Drug Targets. 2010;10(8):932–41. doi:10.2174/156800910793357907.
   PubMed Web of Science ®Google Scholar
• Domingos-Pereira S, Roh V, Hiou-Feige A, Galliverti G, Simon C, Tolstonog GV, Nardelli-Haefliger D. Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model. Oncoimmunology. 2021;10(1):1912473. doi:10.1080/2162402X.2021.1912473.
   PubMed Web of Science ®Google Scholar
• Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B, et al. A novel self-assembled nanoparticle vaccine with HIV-1 Tat(4)(9)(-)(5)(7)/HPV16 E7(4)(9)(-)(5)(7) fusion peptide and GM-CSF DNA elicits potent and prolonged CD8(+) T cell-dependent anti-tumor immunity in mice. Vaccine. 2012;30(6):1071–82. doi:10.1016/j.vaccine.2011.12.029.
   PubMed Web of Science ®Google Scholar
• Oba M, Fukushima S, Kanayama N, Aoyagi K, Nishiyama N, Koyama H, Kataoka K. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing α v β3 and αvβ 5integrins. Bioconjug Chem. 2007;18(5):1415–23. doi:10.1021/bc0700133.
   PubMed Web of Science ®Google Scholar
• Shayakhmetov DM, Eberly AM, Li ZY, Lieber A. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J Virol. 2005;79(2):1053–61. doi:10.1128/JVI.79.2.1053-1061.2005.
   PubMed Web of Science ®Google Scholar
• Khong H, Overwijk WW. Adjuvants for peptide-based cancer vaccines. J Immunother Cancer. 2016;4:56. doi:10.1186/s40425-016-0160-y.
   PubMed Web of Science ®Google Scholar
• Marelli UK, Rechenmacher F, Sobahi TR, Mas-Moruno C, Kessler H. Tumor targeting via integrin ligands. Front Oncol. 2013;3:222. doi:10.3389/fonc.2013.00222.
   PubMedGoogle Scholar
• Zhou X, Liu HY, Zhao H, Wang T. RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment. Onco Targets Ther. 2018;11:5397–405. doi:10.2147/OTT.S169555.
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Stevenson MA, Murshid A. Heat shock proteins, autoimmunity, and cancer treatment. Autoimmune Dis. 2012;2012:486069. doi:10.1155/2012/486069.
   PubMedGoogle Scholar
• Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B, Hightower LE. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14(1):105–11. doi:10.1007/s12192-008-0068-7.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Nakatsura T, Yokomine K, Senju S, Monji M, Hosaka S, Komori H, Yoshitake Y, Motomura Y, Minohara M, et al. DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4 T cells and CD8 T cells. Cancer Sci. 2005;96(10):695–705. doi:10.1111/j.1349-7006.2005.00093.x.
   PubMed Web of Science ®Google Scholar
• Manjili MH, Park J, Facciponte JG, Subjeck JR. HSP110 induces “danger signals” upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology. 2005;210(5):295–303. doi:10.1016/j.imbio.2005.04.002.
   PubMed Web of Science ®Google Scholar